Navigation Links
Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
Date:12/19/2007

Company Meets Highest Listing Standards of any Exchange in the World

TEL-AVIV, Israel, Dec. 19 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (Nasdaq: EMITF) ("EI" or the "Company") today announced that it has qualified to be listed on the NASDAQ Global Select Market effective January 1, 2008, and will continue to trade under the symbol EMITF. This upgraded listing is a result of meeting NASDAQ's highest initial listing standards based on financial and liquidity requirements. Prior to the change, the Company had been listed on the NASDAQ Global Market.

Mr. Shimon Yitzhaki, Elbit Imaging's President, commented: "We are pleased to have achieved this premier designation by meeting NASDAQ's stringent listing requirements, enabling our shares to be traded alongside NASDAQ's top- tier companies. This improved trading status reflects the Company's continued growth and enhanced market share, and is expected to give our stock greater visibility."

About Elbit Imaging Ltd.

Elbit Imaging Ltd. ("EI") is a subsidiary of Europe Israel (M.M.S.) Ltd. EI's activities are divided into the following principal fields: (i) Initiation, construction, operation, management and sale of shopping and entertainment centers in Israel, Central and Eastern Europe and India; (ii) Hotels ownership, primarily in major European cities, as well as operation, management and sale of same through its subsidiary, Elscint Ltd.; (iii) Investments in the research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, through its subsidiary, InSightec Ltd.; and (iv) Other activities consisting of the distribution and marketing of women's fashion and accessories through our wholly-owned Israeli
'/>"/>

SOURCE Elbit Imaging Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
2. Elbit Medical Imaging Ltd. Announces Adjournment of its Annual General Meeting
3. Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing
4. Brain imaging reveals breakdown of normal emotional processing
5. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
6. Fry Construction Selected for High-Profile Medical Imaging Project
7. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
8. Imaging Software Helps Track, Treat Injured Brains
9. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
10. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
11. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)...ERGY Events, ,The Glamorous Red, Se...y 13 /PRNewswire/ -- TrimWater will be on hand May...lanning company in Boston, to,present The Glamorou...mpetition will take place between three of Boston,...30 p.m. at the Church Restaurant and Lounge, 69,Ki...
(Date:5/13/2008)...thy gene into brain slowed Batten disease , ...ne therapy that involves injecting a harmless viru...tive way to slow Batten disease, a rare neurologic... ages of 8 and 12. , Children with the disease,...fuscinosis, are born with a mutated CLN2 gene. Thi...
(Date:5/13/2008)...s to Deliver NBGH Keynote Address, MADISON, N.J.,...s,Incorporated (NYSE: DGX ), the leading provider...announced today that the National Business Group,o...arge U.S. employers, has,presented its 2008 Best E...company for its HealthyQuest employee wellness pro...
(Date:5/13/2008)...wire/ -- Atlantic Information,Services, Inc. (AIS)... saw,substantially smaller cash incentives in 2007...s on performance-based awards, according to AIS,s,...s detailed information,from more than a dozen heal... executives., UnitedHealth Group President and ...
Breaking Medicine News(10 mins):Health News:TrimWater Keeps Boston Beautiful 2Health News:TrimWater Keeps Boston Beautiful 3Health News:Therapy Yields Promise for Fatal Neurological Condition 2Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 2Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 3Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 4Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 5Health News:Health Plan Execs Receive Smaller Bonuses as Companies Push Performance-Based Pay, HPW Reports; Hanway Tops Others in Total Compensation 2
...Kashmiri separatist leader Syed Ali Shah Geelani, ...l documents to go to the US or Britain// for speci...action of the Hurriyat Conference underwent a biop...ations at the Apollo Hospital here Monday. "Docto...
...Scientists have found out that langerin, a protein...d the spread of HIV infection//. New transmission ...ivity of langerin. This research was conducted by ...y Medical Center in Amsterdam which was published ...
...The standard practice of giving oxygen to patients...rd Beasley from Medical Research Institute// of Ne...ly to bring more harm to the patients than good. ...ournal of the Royal Society of Medicine, professor...
...For patients with colorectal cancer who require th...tomy), an experimental procedure may decrease the ...procedure combines both the benefits of laparoscop...from NewYork-Presbyterian Hospital and its academi...
Other Medicine News:Health News:New Surgical Technique Decreases Colorectal OR Time 2
(Date:5/12/2008)... MDX-1100 at Digestive Disease Week .../- Medarex, Inc.,(Nasdaq: ...hase 2 clinical,development program of MDX-1100, a...10 (also known as IP-10), in ulcerative colitis (U...otentially treat UC and RA by,suppressing the infl...
(Date:5/12/2008)...ewswire/ -- GlaxoSmithKline (GSK),in collaboratio...ding,academic breast cancer research network, and ...r Cooperative Group (SOLTI), today announced the s... the role of TYKERB(R) in the,treatment of early b.../or,Trastuzumab Treatment Optimization) will evalu...
(Date:5/9/2008)... in national effort probing for,answers, By Joe...st, Pennsylvania Game Commission, NOTE: Photos...from the,Game Commission,s website (http://www.pg..., HARRISBURG, Pa., May 7 /PRNewswire-USNewswire/...elf on a new frontier: it is working with several,...
(Date:5/9/2008)...wire/ -- Osteoarthritis is a,painful and potential...illion people in the United States. It is caused b...ovel investigational pain medication,tapentadol, a...cant relief,for patients with joint-disease pain, ...ewer gastrointestinal side effects than those trea...
Breaking Medicine Technology:Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 1Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 2Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 3All Pets With Cancer in U S Provided Free Consultation 6323 1All Pets With Cancer in U S Provided Free Consultation 6323 2All Pets With Cancer in U S Provided Free Consultation 6323 3All Pets With Cancer in U S Provided Free Consultation 6323 4National Kidney Foundations 27th Annual Kidney Ball Featuring Entertainment by Patti LaBelle 6321 1Lucian Leape Institute Announces First Roundtable 6319 1Lucian Leape Institute Announces First Roundtable 6319 2Lucian Leape Institute Announces First Roundtable 6319 3
...--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: P...ce(R)", today updated the progress of its Phase II...atic, unresectable,colorectal cancer patients who ...in, and its Phase II clinical trial for first-line...or both,indications may represent orphan drug stat...
..., 2007 - Late-breaking Phase III,clinical trial da...y on Thrombosis and Haemostasis (ISTH) Congress de...erior efficacy in the,prevention of venous thrombo...ment surgery in a head-to-head comparison with,eno... the RECORD3,(REgulation of Coagulation in major O...
Other Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
...Plate at Once , To increase efficiency and throug...t can adapt to the narrow well spacing. Thats exac...or., Available with Impact or Impact2 software (s...ly designed to allow you to transfer an entire col...
...Plate at Once , To increase efficiency and throug...t can adapt to the narrow well spacing. Thats exac...or., Available with Impact or Impact2 software (s...ly designed to allow you to transfer an entire col...
EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th
Designed to create a near bloodless field and provide myocardial protection during target vessel anastomosis. Its unique internal coil and tapered tip have been designed to allow easy, atraumatic ins
Medicine Products: